⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.
Dendritic Cell Antigen Presentation and T-Cell Brain Entry in Tau Pathology
Current understanding
Peripheral dendritic-cell antigen presentation is proposed as a permissive route for T-cell trafficking into the aged brain, where adaptive-immune infiltration is claimed to worsen tau pathology alongside age-related blood–brain barrier leakiness and microglial inflammation [mechanism-plausible]. The claim ties adaptive immunity — historically peripheral in aging-neurodegeneration models — to tauopathy progression, but the current signal comes from news-reported preclinical work rather than primary published trial or lifespan data [expert-opinion].
Evidence log
- 2026-09-25 — A Unified Cause for Loss of Type 1 Dendritic Cell Function in Aging, Cancer, and Chronic Infection: cross-connection with immunosenescence: Both implicate dendritic-cell dysfunction as an upstream gate on cytotoxic T-cell activity — the cDC1 unified-cause paper generalizes the DC → T-cell control axis from the tau/brain-entry context to a shared aging/cancer/chronic-infection substrate. (novelty: 3)
- 2026-09-12 — The Pin1-cis P-tau Axis: A Key Common Early Pathogenic Driver, Biomarker and Therapeutic Target Across Neurodegenerative, Traumatic, and Vascular Cognitive Disorders.: cross-connection with pin1-cis-p-tau-axis: Cis-specific immunotherapy narrative for cis P-tau intersects with dendritic-cell/T-cell tau antigen presentation as parallel adaptive-immunity entry points into tau pathology. (novelty: 3)
Open questions
Related
Contributing findings
Dendritic Cell Antigen Presentation Enables T Cells to Enter the Brain and Contribute to Tau Pathology
11-sep-2026
novelty 3
per-area 3
introduces